Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy.
De Felice
F G
FG
Departamento de Bioquímica Médica, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21944-590, Brazil.
Houzel
J C
JC
Garcia-Abreu
J
J
Louzada
P R
PR
Afonso
R C
RC
Meirelles
M N
MN
Lent
R
R
Neto
V M
VM
Ferreira
S T
ST
D000544:Alzheimer Disease / Q000188:drug therapy / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000737:chemistry / Q000378:metabolism*; D000818:Animals; D002478:Cells, Cultured; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D008845:Microinjections; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009596:Nitrophenols / Q000494:pharmacology*; D017434:Protein Structure, Tertiary; D051381:Rats
D016229:Amyloid beta-Peptides; D018696:Neuroprotective Agents; D009596:Nitrophenols